1.Effects of isoflurane combined with diltiazem on human sperm motility.
Bo XU ; Xiao-Hai WANG ; Li-Jun WANG ; Hui-Jin SUN
National Journal of Andrology 2008;14(12):1109-1111
OBJECTIVETo observe the effects of isoflurane combined with diltiazem on human sperm motility in vitro and to investigate its possible mechanism.
METHODSTen normal semen samples were collected, each divided into 9 groups, one as the control and the others treated in vitro with different concentrations of diltiazem or diltiazem +4.2% isoflurane for 1 hour. Sperm motility was observed with the computer-assisted sperm analyzer.
RESULTSCompared with the control, diltiazem significantly decreased sperm motility at the concentrations of 0.01 g/L, 0.04 g/L, 0.2 g/L and 1 g/L in a dose-dependent manner, and reduced it to approximately 0% at 1 g/L. When combined with 4.2% isoflurane, diltiazem obviously increased sperm motility at 0.01 g/L, markedly decreased it at 0.2 g/L, and effected no significant difference at 0.04 g/L and 1 g/L as compared with the corresponding concentrations of diltiazem alone.
CONCLUSIONThe stimulating effect of isoflurane on sperm motility may be associated with the calcium ion channel in sperm. When completely blocked by diltiazem, this effect may turn into an inhibition of sperm motility.
Adult ; Calcium Channel Blockers ; pharmacology ; Diltiazem ; pharmacology ; Drug Antagonism ; Humans ; Isoflurane ; pharmacology ; Male ; Sperm Motility ; drug effects
2.Effects of Calcium Channel Blockers and Insulin on the Platelet Function in Patients with Diabetes Mellitus.
Young Sik LEE ; Kyung Soo HAHM ; Samuel Y LEE
Yonsei Medical Journal 1986;27(2):132-137
Platelet aggregability was compared between platelets isolated from normal subjects and patients with diabetes mellitus in order to evaluate the effects of calcium channel blockers and insulin on the platelet function. The threshold aggregating concentration of adenosine diphosphate (ADP), which induces the second phase aggregation and reflects the platelet release reaction, was found to be significantly lower in diabetics than in normal subjects (1.8 microM vs 7.5 microM ). It was observed that the second phase aggregation curve induced by ADP was inhibited by in vitro treatment of platelets with insulin (10-100 microU/ml), verapamil (1-10 microM ), and diltiazem (1 microM) in diabetics. The result also shows that the inhibition was enhanced when insulin and calcium channel blockers were used together for in vitro treatment of diabetic platelets. Thus, the present study suggests that the use of calcium channel blockers combined with insulin would be more effective than the use of insulin alone in the prevention of diabetic vascular disease.
Calcium Channel Blockers/pharmacology*
;
Comparative Study
;
Diabetes Mellitus/blood*
;
Diabetes Mellitus/drug therapy
;
Diltiazem/pharmacology
;
Human
;
Insulin/pharmacology*
;
Platelet Aggregation/drug effects*
;
Verapamil/pharmacology
3.Effects of Losartan on acute atrial electrical remodeling.
Yue LI ; Wei-min LI ; Jing-Yi XUE ; Wei HAN ; Shu-sen YANG ; Hong-yue GU
Chinese Medical Journal 2004;117(5):643-646
BACKGROUNDAtrial electrical remodeling (AER) contributes to the maintainance of atrial fibrillation (AF). This study was to compare the effects of Losartan with those of Diltiazem on tachycardia-induced acute AER in rabbits.
METHODSTwenty-one rabbits paced with maximal atrial capture rate for 3 hours in the right atrium (RA) were randomly divided into saline group, Diltiazem group and Losartan group. After autonomic blockage, we measured atrial effective refractory period (AERP), AERP rate adapting feature, AERP dispersion and RA conduction time at basic cycle lengths (BCLs) of 200 ms and 150 ms at baseline, 0.5 hour, 1 hour, 2 and 3 hours after rapid atrial pacing.
RESULTSIn the saline group, there was a prompt decrease in AERP as a result of rapid atrial pacing, and AERP200 and AERP150 were shortened sharply within 0.5 hour of pacing (30.2 +/- 10.5 ms and 24.1 +/- 9.1 ms, respectively). The AERP did not change dramatically in the Diltiazem and Losartan groups. In the saline group, the value of (AERP200-AERP150)/50 ms in high RA was 0.17 +/- 0.08 at baseline and became significantly smaller at 0.5 hour (0.08 +/- 0.06), 1 hour (0.09 +/- 0.06), 2 hours (0.08 +/- 0.04) and 3 hours (0.09 +/- 0.05) (all P < 0.05), suggesting a reduction of rate adaptation of AERP. The value of (AERP200-AERP150)/50 ms in high RA did not change during the 3 hours of pacing in both Diltiazem and Losartan groups. In the saline group, AERP dispersion increased significantly at 2 and 3 hours (P < 0.05). However, Diltiazem could not prevent the increase of AERP dispersion at 3 hours (P < 0.05). During Losartan infusion, the AERP dispersion was no longer increased after rapid atrial pacing. There was no significant difference in RA conduction time among the three groups.
CONCLUSIONLike calcium antagonist Diltiazem, Losartan could prevent AERP shortening and preserve rate adaptation of AERP after rapid atrial pacing. Losartan is more effective than Diltiazem in inhibiting the increase of AERP dispersion.
Animals ; Atrial Fibrillation ; drug therapy ; physiopathology ; Calcium ; metabolism ; Cardiac Pacing, Artificial ; Diltiazem ; pharmacology ; Heart Conduction System ; drug effects ; physiopathology ; Losartan ; pharmacology ; Rabbits ; Refractory Period, Electrophysiological ; drug effects
4.Effect and mechanism of Huangqi Shengmai Decoction in treatment of joint rat model of fatigue and myocardial injury.
Ya-Hui YUAN ; Rong YUAN ; Yu MIAO ; Ya WANG ; Peng-Qi LI ; Jia-Qi HUI ; Yu-Fan PAN ; Zi-Han LI ; Qi-Qi XIN ; Wei-Hong CONG
China Journal of Chinese Materia Medica 2022;47(19):5292-5298
This study aims to investigate the effects and the underlying mechanism of Huangqi Shengmai Decoction(HQSMD) in the treatment of fatigue and myocardial injury in a joint rat model. Wistar rats were assigned into 4 groups: sham, model, diltiazem hydrochloride(positive control), and HQSMD. The joint model of fatigue and myocardial injury was established by 14-day exhausted swimming followed by high ligation of the left anterior descending coronary artery. The rats in the sham group underwent a sham operation without coronary artery ligation or swimming. Since the fourth day after the ligation, swimming was continued in the model group and the drug-treated groups for the following 4 weeks. Meanwhile, the rats in the positive control group and the HQSMD group were respectively administrated intragastrically with diltiazem hydrochloride(20 mg·kg~(-1)·d~(-1)) and HQSMD(0.95 g·kg~(-1)·d~(-1)) for 4 weeks, while the shams and the models were given the same volume of normal saline. The left ventricular ejection fraction(LVEF), left ventricular fractional shortening(LVFS), grip strength, and myocardial pathophysiological changes were measured to evaluate the anti-fatigue and cardioprotective effects of HQSMD. The protein levels of PTEN-induced putative kinase 1(PINK1) and parkin in the myocardium were measured by Western blot to preliminarily elucidate the mechanism of HQSMD in ameliorating myocardial injury by suppressing mitochondrial autophagy. Compared with the shams, the models showed weakened heart function(LVEF and LVFS, P<0.01), decreased grasping ability(P<0.05), elevated blood urea nitrogen(BUN) and aldosterone(ALD) levels(P<0.01), aggravated myocardial fibrosis and connective tissue hyperplasia(P<0.01), and up-regulated protein levels of PINK1(P<0.01) and parkin(P<0.05). Four-week treatment with HQSMD increased the LVEF and LVFS levels(P<0.01), enhanced the grip strength(P<0.01), reduced the serum levels of BUN(P<0.01) and ALD(P<0.05), alleviated the pathological injury and fibrosis in the myocardium(P<0.01), and down-regulated the protein levels of PINK1(P<0.01) and parkin(P<0.05) in heart tissue. The results demonstrate that HQSMD may alleviate myocardial fibrosis and protect myocardium by suppressing the excessive mitochondrial auto-phagic activity and reducing the excessively elevated ALD level, thereby ameliorating fatigue and myocardial injury.
Rats
;
Animals
;
Ventricular Function, Left
;
Rats, Sprague-Dawley
;
Stroke Volume
;
Diltiazem/pharmacology*
;
Rats, Wistar
;
Cardiomyopathies
;
Heart Injuries
;
Fibrosis
;
Protein Kinases
;
Ubiquitin-Protein Ligases
5.Experimental study on the option of antispasmodic drugs for radial artery in elderly patients with coronary atherosclerotic heart disease.
Liu-zhong SHEN ; Xu-jun CHEN ; Xin CHEN ; Ming XU ; Li-ming WANG ; Ying-shuo JIANG
Chinese Journal of Surgery 2010;48(19):1488-1491
OBJECTIVETo compare the relief effect of diltiazem, papaverine and nitroglycerin on radial artery spasm in elderly patients with coronary atherosclerotic heart disease.
METHODSSixty patients aged beyond 70 years underwent coronary artery bypass grafting (CABG) with autologous radial artery from July 2009 to March 2010. Redundant radial artery was collected and the relief function of different drugs was evaluated through "organ bath" technique in vitro. All the patients were randomly divided into 3 groups based on different antispasmodic drugs: diltiazem, papaverine and nitroglycerin. Thirty seconds free blood flow of radial artery and hemodynamic parameters (heart rate, mean arterial pressure and central venous pressure) were assessed before and after intra-radial administration of diltiazem, papaverine and nitroglycerin in vivo.
RESULTSAll three drugs could relieve radial artery spasm in different levels and the eventual relief rate was over 80%. Only nitroglycerin could relax radial artery completely, the relief capacity of nitroglycerin, diltiazem and papaverine decreased in order. There was no significant difference in the hemodynamic parameters before and after the injection. Blood flow of radial artery increased in nitroglycerin group [(42 ± 10) ml/30 s vs. (28 ± 7) ml/30 s, P < 0.05] while there was no significant difference in diltiazem [(23 ± 10) ml/30 s vs. (25 ± 8) ml/30 s, P > 0.05] and papaverine group [(25 ± 10) ml/30 s vs. (24 ± 9), P > 0.05].
CONCLUSIONSNitroglycerin could relieve vasospasm of radial artery effectively and increased blood flow. Nitroglycerin is the suitable antispasmodic drug for radial artery in the elderly patients with coronary atherosclerotic heart disease compare with diltiazem and papaverine.
Aged ; Aged, 80 and over ; Coronary Artery Bypass ; Coronary Artery Disease ; physiopathology ; surgery ; Diltiazem ; pharmacology ; Female ; Follow-Up Studies ; Humans ; Male ; Nitroglycerin ; pharmacology ; Papaverine ; pharmacology ; Parasympatholytics ; pharmacology ; Radial Artery ; drug effects ; physiology ; transplantation
6.Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine..
Bukhtiar H SHAH ; Huma RASHEED ; Ibrahim H RAHMAN ; Amir H SHARIFF ; Fatima L KHAN ; Hina B RAHMAN ; Sara HANIF ; Sheikh A SAEED
Experimental & Molecular Medicine 2001;33(4):226-233
Our recent studies have shown that co-activation of Gq and Gi proteins by 5-hydroxytryptamine (5-HT) and adrenaline show synergism in human platelet aggregation. This study was conducted to examine the mechanism(s) of synergistic interaction of 5-HT and platelet activating factor (PAF) in human platelets. We show that PAF, but not 5-HT, increased platelet aggregation in a concentration-dependent manner. However, low concentrations of 5-HT (2 microM) potentiated platelet aggregation induced by subthreshold concentration of PAF (40 nM) indicating a synergistic interaction between the two agonists and this synergism was blocked by receptor antagonists to either 5-HT or PAF. 5-HT also potentiated the effect of PAF on thromboxane A2 (TXA2) formation and phosphorylation of extracellularly regulated mitogen-activated protein kinases (ERK1/2). The synergism of 5-HT and PAF in platelet aggregation was inhibited by calcium (Ca2+) channel blockers, verapamil and diltiazem, phospholipase C (PLC) inhibitor, U73122, cyclooxygenase (COX) inhibitor, indomethacin, and MEK inhibitor, PD98059. These data suggest that synergistic effect of 5-HT and PAF on human platelet aggregation involves activation of PLC/Ca2+, COX and MAP kinase pathways.
Diltiazem/pharmacology
;
Dose-Response Relationship, Drug
;
Drug Synergism
;
Estrenes/pharmacology
;
Flavones/pharmacology
;
Human
;
In Vitro
;
Indomethacin/pharmacology
;
Kinetics
;
Mitogen-Activated Protein Kinases/metabolism
;
Phosphorylation/drug effects
;
Platelet Activating Factor/*pharmacology
;
Platelet Activation/drug effects
;
Platelet Aggregation/*drug effects/physiology
;
Pyrrolidinones/pharmacology
;
Serotonin/*pharmacology
;
Thromboxane A2/biosynthesis
;
Verapamil/pharmacology
7.Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine..
Bukhtiar H SHAH ; Huma RASHEED ; Ibrahim H RAHMAN ; Amir H SHARIFF ; Fatima L KHAN ; Hina B RAHMAN ; Sara HANIF ; Sheikh A SAEED
Experimental & Molecular Medicine 2001;33(4):226-233
Our recent studies have shown that co-activation of Gq and Gi proteins by 5-hydroxytryptamine (5-HT) and adrenaline show synergism in human platelet aggregation. This study was conducted to examine the mechanism(s) of synergistic interaction of 5-HT and platelet activating factor (PAF) in human platelets. We show that PAF, but not 5-HT, increased platelet aggregation in a concentration-dependent manner. However, low concentrations of 5-HT (2 microM) potentiated platelet aggregation induced by subthreshold concentration of PAF (40 nM) indicating a synergistic interaction between the two agonists and this synergism was blocked by receptor antagonists to either 5-HT or PAF. 5-HT also potentiated the effect of PAF on thromboxane A2 (TXA2) formation and phosphorylation of extracellularly regulated mitogen-activated protein kinases (ERK1/2). The synergism of 5-HT and PAF in platelet aggregation was inhibited by calcium (Ca2+) channel blockers, verapamil and diltiazem, phospholipase C (PLC) inhibitor, U73122, cyclooxygenase (COX) inhibitor, indomethacin, and MEK inhibitor, PD98059. These data suggest that synergistic effect of 5-HT and PAF on human platelet aggregation involves activation of PLC/Ca2+, COX and MAP kinase pathways.
Diltiazem/pharmacology
;
Dose-Response Relationship, Drug
;
Drug Synergism
;
Estrenes/pharmacology
;
Flavones/pharmacology
;
Human
;
In Vitro
;
Indomethacin/pharmacology
;
Kinetics
;
Mitogen-Activated Protein Kinases/metabolism
;
Phosphorylation/drug effects
;
Platelet Activating Factor/*pharmacology
;
Platelet Activation/drug effects
;
Platelet Aggregation/*drug effects/physiology
;
Pyrrolidinones/pharmacology
;
Serotonin/*pharmacology
;
Thromboxane A2/biosynthesis
;
Verapamil/pharmacology
8.Diltiazem enhances food intake and gastrointestinal function in rats.
Li-Na WANG ; Sheng-Li LI ; Chuang-Hong LI ; Chen-Xu ZHANG ; Hui YUAN ; Xin-Ping LI
Acta Physiologica Sinica 2012;64(2):187-192
The present study was to investigate the effects of diltiazem, a ghrelin receptor agonist, on food intake and gastrointestinal functions in rats. Rats were intragastrically administered with diltiazem solution (daily 16 mg/kg, 30 mg/kg or 80 mg/kg, 30 d), and the rats with saline as control. To detect the effects of diltiazem on food intake and body weight, the average daily food intake and body weight were recorded, and the serum metabolic hormones of plasma growth hormone (GH) and neuropeptide Y (NPY) were tested by radioimmunoassay. By means of the spectrophotometer and the modified Mett's method, the effects of diltiazem on rat's gastrointestinal function and pepsin activity were tested, respectively. In addition, the gastric juice's acidity of rats was detected by titration and the secretion amount was calculated. The results showed that the food intake and body weight were maximally promoted by diltiazem at the dose of 30 mg/kg daily (30 d). The average daily food intake and body weight were significantly increased, and the serum concentrations of GH and NPY were also remarkably increased in diltiazem-treated groups compared with those in control group. The results also showed that the gastric emptying rate, gastric acid secretion and the activity of pepsin were significantly increased in diltiazem-treated group compared with those in control group. These results suggest that diltiazem induces enhancement of eating, in the same time, it can also stimulate the gastrointestinal function and regulate growth of rat.
Animals
;
Body Weight
;
drug effects
;
Diltiazem
;
pharmacology
;
Eating
;
drug effects
;
Female
;
Gastric Emptying
;
drug effects
;
Gastrointestinal Motility
;
drug effects
;
Gastrointestinal Tract
;
physiology
;
Growth Hormone
;
blood
;
Neuropeptide Y
;
blood
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Ghrelin
;
agonists
9.Protective effect of Tongxinluo Ultramicro-pulverization on experimental myocardial infarction of rats.
Yan-fen ZHANG ; Hui-ming ZHU ; Hong-tao WANG ; Si-wen TANG ; Hui-xin ZHANG ; Xiao-li WU ; Yi-ling WU
China Journal of Chinese Materia Medica 2008;33(15):1877-1880
OBJECTIVETo study the effects of Tongxinluo ultramicro-pulverization (TXLU) on experimental myocardial infarction and platelet aggregation of rats, investigate its mechanisms on ischemia heart disease and offer a reference to clinical usage.
METHODRats were separated randomly into 7 groups: sham, model, diltiazem (0.15 mg x kg(-1)), TXL(1.2 g x kg(-1)), TXLU (1.2, 0.6, 0.3 g x kg(-1)). The experimental myocardial infarction was induced with ligating the left anterior descending branch of the coronary of rats. The infarction size was determined after myocardium tissue was stained with 2,3,5-triphenyltetrazolium chloride (TTC). And the serum of rats was separated to analyze CK, LDH, SOD, MDA. Another 60 rats were separated randomly into 6 groups: control, aspirin (0.15 mg x kg(-1)), TXL (1.2 g x kg(-1)), TXLU (1.2 ,0.6,0.3 g x kg(-1)). The rat platelet aggregation was induced with adenosine diphosphate (ADP) and collagen to observe the inhibitory effects of TXLU.
RESULTTXLU could relieve the myocardial infarction size and weight stained with TTC significantly, the myocardial infarction size of the three groups of TXLU were (2.7 +/- 2.1)%, (3.4 +/- 1.2)%, (2.8 +/- 1.8)%, compared with model group (8.9 +/- 5.9)%, P < 0.05 or P < 0.01. The myocardial infarction weight of the three groups of TXLU were (8.4 +/- 3.5)%, (8.7 +/- 4.1)%, (9.7 +/- 4.1)%, compared with model group (l2.2 +/- 3.6)% P < 0.05 or P < 0. 01. And the content of MDA and the activities of CK and LDH in rats subjected with ligation of coronary artery were inhibited obviously too, compared with model group P < 0.05 or P < 0.01, then the activity of SOD increased. TXLU could inhibit the maximum percentage of rats platelet aggregation induced with ADP and collagen, the maximum percentage of platelet aggregation induced with ADP were (26.9 +/- 9.2)%, (24.4 +/- 13.4)%, (30.6 +/- 12.2)%, compared with control group (44.3 +/- 15. 7)% P < 0.05 or P < 0.01; The maximum percentage of platelet aggregation induced with collagen were (33.8 +/- 6.9)%, (32.1 +/- 8.3)%, (41.5 +/- 7.8)%, compared with control group (49.2 +/- 15.9)%, P < 0.05 or P < 0.01.
CONCLUSIONThe experiment results indicated that TXLU could protect myocardial tissue of rats from ischemic injury and the mechanism may be related with antioxidation and inhibiting platelet aggregation, and the results also suggested TXLU could lower clinical dosage.
Adenosine Diphosphate ; pharmacology ; Animals ; Aspirin ; pharmacology ; Diltiazem ; pharmacology ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Female ; Male ; Medicine, Chinese Traditional ; methods ; Myocardial Infarction ; blood ; chemically induced ; drug therapy ; pathology ; Platelet Aggregation ; drug effects ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Tetrazolium Salts ; pharmacology
10.Effects of methyl protodioscin on Ca2+i and ATPase activity in cardiomyocytes and analysis of mechanisms.
Zong NING ; Yikui LI ; Rongli ZHANG
China Journal of Chinese Materia Medica 2010;35(1):80-83
OBJECTIVETo study the effects of methyl protodioscin on the [Ca2+]i and the ATPase activity in cardiomyocytes, as well as their mechanisms.
METHODThe cardiomyocytes were randomly divided into three groups, the control group treated with no serumal DMEM, the MPD group treated with MPD and the dilthiazem group treated with dilthiazem. Fluorospectrophotometer was used to determined the level of myocardial cell intracellular Ca2+ [Ca2+]i. In the experiment of ATPase activity on cellular membrane, the cardiomyocytes were randomly divided into two groups, the control group treated with no serumal DMEM, the MPD group treated with MPD. The activity of Na+-K+-ATPase,Ca2+-Mg2+-ATPase and Mg2+-ATP ATPase were determined. The quantitative analysis of SERCA2a mRNA expression was studied by RT-PCR that the groups and treatments in cardiomyocytes same as the experiment for ATPase activity assay.
RESULTUnder the quiescent condition, compared to the control group, the level of [Ca2+]i in cardiomyocytes of the MPD group and dilthiazem group was no different. After treatment with 40 mmol x L(-1) KCl, [Ca2+] was significantly lower in the MPD group and the dilthiazem group, and the intensity of peak value in time course of 60 s, the dilthiazem group and the MPD group also were lower than the control group (P < 0.001). Ca2+-Mg2+-ATPase and Na+-K+-ATPase in cultured rat were increased after treated with MPD compared to treatment with no serumal DMEM (P < 0.05, P < 0.01), but Mg2+-ATPase in these groups had no different. The expression of SERCA2a mRNA between the MPD group and the control group was no different. MPD could not up-regulated or down-regulated SERCA2a in endocytoplasmic reticulum.
CONCLUSIONMethyl protodioscin could block the volt dependent form calcium channel in cellular membrane, and up-regulate the function of sodium pump and calcium pump, so that it could remain low calcium in the internal environment in cardiomyocytes.
Animals ; Ca(2+) Mg(2+)-ATPase ; metabolism ; Calcium ; metabolism ; Calcium Channels ; drug effects ; Cell Membrane ; drug effects ; metabolism ; Cells, Cultured ; Diltiazem ; pharmacology ; Diosgenin ; analogs & derivatives ; pharmacology ; Enzyme Activation ; drug effects ; Female ; Male ; Myocytes, Cardiac ; drug effects ; metabolism ; Rats ; Rats, Sprague-Dawley ; Saponins ; pharmacology ; Sarcoplasmic Reticulum Calcium-Transporting ATPases ; metabolism ; Sodium-Potassium-Exchanging ATPase ; drug effects